ViolanteECurrieMD

PubMed

• 35 citations
  Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
  Arti Hurria, Shari Goldfarb, Carol Rosen, Jimmie C. Holland, Enid Zuckerman, Mark S. Lachs, Matthew Witmer, Wilfred G. van Gorp, Monica Fornier, Gabriella D'Andrea, Ma...> ;Breast Cancer Research and Treatment. 2006 Mar 16
• 27 citations
  A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
  Modi, S., Currie, V. E., Seidman, A. D., Bach, A. M., Panageas, K. S., Theodoulou, M., Moasser, M. M., D'Andrea, G. M., Lake, D. E., Choi, J., Norton, L., Hudis, C. A.> ;Clinical breast cancer. 2005 May 19
• Lack of Increased Cardiac Toxicity with Sequential Doxorubicin and Paclitaxel
  Clifford A. Hudis, Louise Riccio, Andrew D. Seidman, José Baselga, Violante Currie, David Fennelly, Teresa Gilewski, David Lebwohl, ME Moynahan, George Raptis, Antonel...> ;Cancer Investigation. 1998 Jan 1
• Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
  Andrew D. Seidman, Clifford A. Hudis, McCaffrey Ja, William P. Tong, Violante Currie, ME Moynahan, Maria Theodoulou, I. Tepler, M. Gollub, Larry Norton> ;Seminars in Oncology. 1997 Oct 1
• Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
  Clifford A. Hudis, Andrew D. Seidman, John Crown, Casilda Balmaceda, R. Freilich, Theresa Gilewski, Thomas B. Hakes, Violante Currie, David Lebwohl, José Baselga, Geor...> ;Journal of Clinical Oncology. 1996 Jan 1
• Taxol (Paclitaxel) plus Recombinant Human Granulocyte Colony-Stimulating Factor in the Treatment of Metastatic Breast Cancer
  Andrew D. Seidman, Larry Norton, Bonnie Reichman, John Crown, Tzy-Jyun Yao, Thomas B. Hakes, David Lebwohl, Theresa Gilewski, Clifford A. Hudis, Antonella Surbone, Vio...> ;Oncology. 1994 Jan 1
• A clinical trial of amygdalin (Laetrile) in the treatment of human cancer.
  Moertel CG, Fleming TR, Rubin J, Kvols LK, Sarna G, Koch R, Currie VE, Young CW, Jones SE, Davignon JP> ;N. Engl. J. Med.. 1982-01-28
• Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.
  Wong PP, Currie VE, Mackey RW, Krakoff IH, Tan CT, Burchenal JH, Young CW> ;Cancer Treat Rep. 1979-08-01
• Clinical pharmacologic and therapeutic studies of bleomycin given by continuous infusion.
  Krakoff IH, Cvitkovic E, Currie V, Yeh S, LaMonte C> ;Cancer. 1977-11-01
• Specific adoptive and passive immunotherapy be parabiosis for syngeneic mouse and rat tumors.
  Southam CM, Bower EB, Currie VE, Babcock VI> ;Ann. N. Y. Acad. Sci.. 1976-01-01
• Experimental and clinical studies on nucleoside analogs as antitumor agents.
  Burchenal JH, Currie VE, Dowling MD, Fox JJ, Krakoff IH> ;Ann. N. Y. Acad. Sci.. 1975-08-08
• Phase II study of vindesine sulfate in the therapy for advanced renal carcinoma.
  Wong, P. P., Yagoda, A., Currie, V. E., Young, C. W.> ;Cancer Treat Rep. 1977 Dec
• Phase II evaluation of metoprine in patients with advanced colorectal carcinoma.
  Lynch, G., Kemeny, N., Currie, V.> ;Cancer Treat Rep. 1981 Jan 01
• Phase II evaluation of metoprine with leucovorin rescue in patients with advanced colorectal carcinoma.
  Lynch, G., Currie, V., Kemeny, N.> ;Cancer Clin Trials. 1981
• Phase I evaluation of piperazinedione in patients with advanced cancer.
  Currie, V., Woodcock, T., Tan, C., Krakoff, I., Young, C.> ;Cancer Treat Rep. 1979 Jan
• Phase II trial of pyrazofurin in malignant melanoma.
  Budman, D., Currie, V., Wittes, R.> ;Cancer Treat Rep. 1977 Dec
• Phase II evaluation of pyrazofurin in patients with carcinoma of the lung.
  Gralla, R. J., Currie, V. E., Wittes, R. E., Golbey, R. B., Young, C. W.> ;Cancer Treat Rep. 1978 Mar
• Phase I and clinical pharmacologic evaluation of Lonidamine in patients with advanced cancer.
  Young, C. W., Currie, V. E., Kim, J. H., O'Hehir, M. A., Farag, F. M., Kinahan, J. E.> ;Oncology. 1984
• Phase II trial of pyrazofurin, alone and in combination with trifluorothymidine, in non-Hodgkin''s lymphoma.
  Warrell, R. P., Currie, V., Kempin, S., Young, C.> ;Cancer Treat Rep. 1979 Aug
• Phase II trial of pyrazofurin in advanced head and neck cancer.
  Cheng, E., Currie, V., Wittes, R. E.> ;Cancer Treat Rep. 1979 Nov 01
• Phase I trial of metoprine in patients with advanced cancer.
  Currie, V. E., Kempin, S. J., Young, C. W.> ;Cancer Treat Rep. 1980 Aug 01
• Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
  Currie, V. E., Warrell, R. P., Arlin, Z., Tan, C., Sirotnak, F. M., Greene, G., Young, C. W.> ;Cancer Treat Rep. 1983 Feb
• Phase I trial of vindesine in patients with advanced cancer.
  Currie, V. E., Wong, P. P., Krakoff, I. H., Young, C. W.> ;Cancer Treat Rep. 1978 Sep
• Patients' pretreatment expectations of chemotherapy-related nausea are an independent predictor of anticipatory nausea.
  Montgomery, G. H., Tomoyasu, N., Bovbjerg, D. H., Andrykowski, M. A., Currie, V. E., Jacobsen, P. B., Redd, W. H.> ;Ann Behav Med. 1998
• Phase II trial of 10-deaza-aminopterin in advanced breast cancer.
  Thongprasert, S., Currie, V. E., Budman, D.> ;Cancer Treat Rep. 1987 Jan 01
• Join now to see all